Xeris Pharmaceuticals Inc. (XERS) Reports In-Line Q2 EPS ; Offers Guidance

Go back to Xeris Pharmaceuticals Inc. (XERS) Reports In-Line Q2 EPS ; Offers Guidance
(NASDAQ: XERS) Delayed: 6.90 --0 (-0%)
Previous Close $6.90    52 Week High
Open $6.90    52 Week Low
Day High $6.90    P/E N/A 
Day Low $6.90    EPS
Volume 215